About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

PD4PD:Partnered Dance for Parkinson Disease | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2/3NCT01388556

PD4PD:Partnered Dance for Parkinson Disease

Exercise is often noted as an important component in a comprehensive approach to the management of Parkinson disease (PD). Most studies of exercise have examined the effects of short-term intervention...

Lead sponsor: Washington University School of Medicine•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Washington University School of Medicine

Collaborators

Parkinson's Disease Foundation

Age

30 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•normal central and peripheral neurological function
•at least grade 4/5 strength and normal joint ranges of motion in both legs, - vision corrected to 20/40 or better
•able to walk independently for 10 feet with or without an assistive device, - normal somatosensory function in the feet (2-point discrimination, vibration, joint kinesthesia, and light touch)
•no history of vestibular disease

Exclusion Criteria

•serious medical problem
•evidence of abnormality other than PD-related changes on brain imaging (previously done for clinical evaluations-not part of this research)
•history or evidence of neurological deficit other than PD that could interfere, such as previous stroke or muscle disease
•history or evidence of orthopedic, muscular, or psychological problem

Related studies

Apathy in Parkinson Disease TMS Study

NCT06087926 · Parkinson Disease

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

NCT07642908 · Parkinson Disease

RECRUITINGPhase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

NCT06680830 · Parkinson Disease, Parkinson, and more

Cognitive Decline Following Deep Brain Stimulation

NCT05822388 · Parkinson Disease, Movement Disorders

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

NCT06965374 · Parkinson Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 9, 2015Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment62

Start dateJul 2009

Last updatedDec 9, 2015

Condition

Parkinson Disease

Locations shown

Washington University School of Medicine

St Louis, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 9, 2015Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions